US FDA Gives Leucovorin Unprecedented Path To New Claim Amid ‘Autism Crisis’

 
• By Bridget Silverman
  
The US FDA plans to give leucovorin a shortcut to a cerebral folate deficiency approval and the autism market. (Shutterstock)

More from Approval Standards

More from Generics